Cedrus »

Akebia Therapeutics shares owned by Cedrus

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Cedrus from 13F filings

Historical chart of Cedrus investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Cedrus consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Cedrus

Quarter filed Position value Share count Share price at filing
2024-09-30 $18k 14k 1.32
2024-06-30 $14k 14k 1.02

More positions owned by Cedrus

Vanguard Index Fds Growth Etf (VUG)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
First Tr Exchange-traded Ft Vest Ris (RDVI)
First Tr Exchng Traded Fd Vi Low Dur Strtgc (LDSF)
Vanguard World Mega Cap Val Etf (MGV)
Wisdomtree Tr Glb Us Qtly Div (DNL)
Ishares Tr MRGSTR MD CP GRW (IMCG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exchange-traded First Tr Enh New (FTSM)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Vanguard Index Fds Value Etf (VTV)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)

View all positions for Cedrus

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics